Analysts who follow Kazia Therapeutics Ltd (KZIA) on average expect it to gain 696.02% over the next twelve months. Those same analysts give the stock an average rating of Hold. That average rating earns Kazia Therapeutics Ltd an Analyst Ranking of 5, which means it ranks higher than 5 of stocks, based on data compiled by InvestorsObserver.
Wall Street analysts are rating KZIA a Hold today. Find out what this means to you and get the rest of the rankings on KZIA!